Compounds > carbachol
Page last updated: 2024-11-07

carbachol and Triple Negative Breast Neoplasms

carbachol has been researched along with Triple Negative Breast Neoplasms in 1 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Español, AJ1
Salem, A1
Di Bari, M1
Cristofaro, I1
Sanchez, Y1
Tata, AM1
Sales, ME1

Other Studies

1 other study available for carbachol and Triple Negative Breast Neoplasms

ArticleYear
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
    PloS one, 2020, Volume: 15, Issue:9

    Topics: Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Arecoline; ATP

2020